• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG PK PAPYRUS US; COVERED CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG PK PAPYRUS US; COVERED CORONARY STENT SYSTEM Back to Search Results
Model Number 434893
Medical Device Problem Code Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/03/2025
Type of Reportable Event Malfunction
Event or Problem Description
A pk papyrus covered stent system was selected for treatment of a type ii perforation in mid lcx.In order to stop bleeding, balloon dilatation was performed first.Then the pk papyrus was introduced but did not cross.Bleeding was stopped with balloon dilatation.
 
Additional Manufacturer Narrative
The affected pk papyrus stent system was not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies could also not be obtained.The provided clinical information (pk papyrus device registration form, discharge letter and cathlab report) and the production documentation was reviewed to establish whether a device deficiency contributed to this event.Review of the production documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation and the conducted review no manufacturing related root cause could be identified.The treating physician rated the occurrence as device-related but non-procedure-related complication.It should be noted that the ifu states not to re-insert the stent system as the stent and/or the delivery system may have been damaged during the initial attempt to cross the lesion or during withdrawal.Pk papyrus is indicated for the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter.As such, this device is typically used in emergent response to a life-threatening adverse procedural event unrelated to use of the pk papyrus.
 
Event or Problem Description
A pk papyrus covered stent system was selected for treatment of a type ii perforation in mid lcx.In order to stop bleeding, balloon dilatation was performed first.Then the pk papyrus was introduced but did not cross.Bleeding was stopped with balloon dilatation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PK PAPYRUS US
Common Device Name
COVERED CORONARY STENT SYSTEM
Manufacturer (Section D)
BIOTRONIK AG
ackerstrasse 6
bulach, zurich 8180
SZ  8180
Manufacturer (Section G)
BIOTRONIK AG
ackerstrasse 6
bulach, zurich 8180
SZ   8180
Manufacturer Contact
ramona ergler
ackerstrasse 6
bulach, zurich 8180
SZ   8180
MDR Report Key24321677
Report Number8043892-2026-01195
Device Sequence Number9966474
Product Code NIV
UDI-Device Identifier07640130447219
UDI-Public(01)07640130447219(17)270603(10)05251342
Combination Product (Y/N)N
Initial Reporter StateNV
Initial Reporter CountryUS
PMA/510(K) Number
H17004
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number434893
Device Lot Number05251342
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/19/2026
Supplement Date Received by Manufacturer01/19/2026
Initial Report FDA Received Date02/12/2026
Supplement Report FDA Received Date04/15/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/04/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-